MOLECULAR MECHANISMS OF THE EFFICACY OF OSTEOMED FORTE IN PSORIATIC ARTHROPATHY

Download full text PDF
Issue: 
5
Year: 
2016

I. Sarvilina, MD «Novomeditsina» Medical Center, Rostov-on-Don

Positive changes have been found in the activity of psoriatic arthropathy (PA) caused by the molecular components of the mechanism of action of Osteomed Forte during basic therapy. The drug is promising in treating and preventing PA and well tolerated.
Keywords: 
psoriatic arthropathy
treatment
prevention
Osteomed Forte

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Galljamova Ju. A. Psoriaticheskaja artropatija // Lechaschij vrach. – 2008; 1. 3: 28.
  2. Znamenskaja L.F., Melehina L.E., Bogdanova E.V. i dr. Zabolevaemost' i rasprostranennost' psoriaza v Rossijskoj Federatsii // Vestn. dermatol. i venerol. – 2012; 5: 20–9.
  3. Piruzjan L.A., Goldenkova I.V., Korsunskaja I.M. i dr. Ekogeneticheskie aspekty pri sozdanii protokolov vedenija patsientov s psoriazom // Problemy standartizatsii v zdravoohranenii. – 2006; 6: 7–14.
  4. Strukov V.I. i dr. Sposob i preparat dlja profilaktiki i lechenija atipichnogo osteoporoza s normal'noj ili povyshennoj mineralizatsiej kostnoj tkani s nalichiem polostnyh obrazovanij v trabekuljarnyh otdelah kostej (i emu blizkih sostojanijah pri izbytochnoj masse i metabolichne-skom sindrome). Patent RF na izobretenie №2497533. Zaregistrirovan 10.11.13.
  5. Strukov V.I., Elistratov D.G., Maksimova M.N. i dr. Sposob diagnosti ki osteoporoza i opredelenija effektivnosti preparata v lechenii zabole-vanija // Farmatsija. – 2013; 8: 40–3.
  6. Ellis C., Hermann R., Gorsulowsky D. et al. Etretinate therapy reduces in patient treatment of psoriasis // J. Am. Acad. Dermatol. – 1987; 17: 787–91.
  7. Feldmann S., Garton R., Averrett W. et al. Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost // Expert Opin. Pharmacother. – 2003; 4: 1525–33.
  8. Henseler T., Christophers E. Psoriasis of early and late onset: characterization 8. of two types of psoriasis vulgaris // J. Am. Acad. Dermatol. – 1985; 13: 450–6.
  9. Mease P., Goffe B., Metz J. et al. Etanercept in the treatment of psoriatic 9. arthritis and psoriasis: a randomised trial // Lancet. – 2000; 356 (9227): 385–90.
  10. Mease P., Ory P., Sharp J. et al. Adalimumab for long-term treatment of 10. psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT) // Ann. Rheum. Dis. – 2009; 68 (5): 702–9.